This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Disruptive Pharma Ab. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Ottilia Arvén: Innovator in Pharmaceutical Science
Introduction
Ottilia Arvén is a notable inventor based in Uppsala, Sweden. She has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. Her work focuses on enhancing the efficacy and delivery of active pharmaceutical ingredients.
Latest Patents
Ottilia Arvén holds a patent for "Amorphous active pharmaceutical ingredients comprising substantially amorphous mesoporous magnesium carbonate." This patent describes a solid and substantially amorphous admixture that includes Sorafenib as the active pharmaceutical ingredient (API) and a particulate anhydrous and substantially amorphous mesoporous magnesium carbonate (MMC). The patent also outlines a method for manufacturing this formulation and an oral pharmaceutical formulation that incorporates the solid substantially amorphous admixture. She has 1 patent to her name.
Career Highlights
Ottilia is currently associated with Disruptive Pharma AB, where she continues to push the boundaries of pharmaceutical innovation. Her work is characterized by a commitment to improving drug formulations and patient outcomes.
Collaborations
Some of her notable coworkers include Peter Åsberg and Tuulikki Lindmark, who contribute to her research and development efforts in the pharmaceutical sector.
Conclusion
Ottilia Arvén is a pioneering inventor whose work in pharmaceutical science is making a significant impact. Her innovative approaches to drug formulation are paving the way for advancements in the field.